Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.430
+0.020 (0.59%)
At close: Dec 16, 2025, 4:00 PM EST
3.480
+0.050 (1.46%)
After-hours: Dec 16, 2025, 7:49 PM EST
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $371.2 million as of December 16, 2025. Its market cap has decreased by -71.32% in one year.
Market Cap
371.20M
Enterprise Value
173.49M
1-Year Change
-71.32%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since January 5, 2018, Rocket Pharmaceuticals's market cap has decreased from $413.75M to $371.20M, a decrease of -10.28%. That is a compound annual growth rate of -1.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 369.04M | -71.87% |
| Dec 31, 2024 | 1.31B | -51.45% |
| Dec 29, 2023 | 2.70B | 82.43% |
| Dec 30, 2022 | 1.48B | 5.29% |
| Dec 31, 2021 | 1.41B | -57.65% |
| Dec 31, 2020 | 3.32B | 169.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |